(Q38059780)

28 August 2017

Future directions in cancer prevention. (English)

1 reference

28 August 2017

Asad Umar

1

1 reference

28 August 2017

Barbara K Dunn

series ordinal

2

1 reference

28 August 2017

Peter Greenwald

series ordinal

3

1 reference

28 August 2017

language of work or name

English

0 references

publication date

15 November 2012

1 reference

28 August 2017

Nature Reviews Cancer

1 reference

28 August 2017

12

1 reference

28 August 2017

12

1 reference

28 August 2017

835-848

1 reference

https://scigraph.springernature.com/pub.10.1038/nrc3397

28 August 2017

0 references

cites work

Global cancer statistics

1 reference

Cancer prevention: from 1727 to milestones of the past 100 years

31 March 2020

1 reference

Landmarks in the history of cancer epidemiology

31 March 2020

1 reference

31 March 2020

The Hallmarks of Cancer

1 reference

Hallmarks of Cancer: The Next Generation

31 March 2020

1 reference

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

31 March 2020

1 reference

Molecular targets for cancer chemoprevention

31 March 2020

1 reference

Cancer prevention by targeting angiogenesis

31 March 2020

1 reference

Clinical and epidemiological issues in mammographic density.

31 March 2020

1 reference

The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today

31 March 2020

1 reference

Epidemiological and clinical studies of nutrition

31 March 2020

1 reference

Alarming colorectal cancer incidence trends: a case for early detection and prevention

31 March 2020

1 reference

Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial

31 March 2020

1 reference

Cellular proliferation, apoptosis and angiogenesis: molecular targets for nutritional preemption of cancer

31 March 2020

1 reference

Cancer prevention with natural compounds

31 March 2020

1 reference

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

31 March 2020

1 reference

Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

31 March 2020

1 reference

Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.

31 March 2020

1 reference

A nutrient approach to prostate cancer prevention: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)

31 March 2020

1 reference

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

31 March 2020

1 reference

Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland

31 March 2020

1 reference

Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer

31 March 2020

1 reference

Understanding the Warburg effect: the metabolic requirements of cell proliferation

31 March 2020

1 reference

Cell biology. Warburg effect and redox balance.

31 March 2020

1 reference

The link between the metabolic syndrome and cancer

31 March 2020

1 reference

31 March 2020

De-Meaning of Metabolism

1 reference

Nutrition, insulin, insulin-like growth factors and cancer

31 March 2020

1 reference

Circulating concentrations of insulin-like growth factor I and risk of breast cancer

31 March 2020

1 reference

The insulin and insulin-like growth factor receptor family in neoplasia: an update

31 March 2020

1 reference

Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.

31 March 2020

1 reference

Chemoprevention meets glucose control

31 March 2020

1 reference

Metformin: a therapeutic opportunity in breast cancer

31 March 2020

1 reference

Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth

31 March 2020

1 reference

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

31 March 2020

1 reference

What's preventing us from preventing type 2 diabetes?

31 March 2020

1 reference

PTEN mutations as a cause of constitutive insulin sensitivity and obesity.

31 March 2020

1 reference

Cowden syndrome: a critical review of the clinical literature

31 March 2020

1 reference

Energy restriction and the risk of spontaneous mammary tumors in mice: a meta-analysis

31 March 2020

1 reference

Insights into the beneficial effect of caloric/ dietary restriction for a healthy and prolonged life.

31 March 2020

1 reference

The Okinawan diet: health implications of a low-calorie, nutrient-dense, antioxidant-rich dietary pattern low in glycemic load

31 March 2020

1 reference

Energy restriction early in life and colon carcinoma risk: results of The Netherlands Cohort Study after 7.3 years of follow-up

31 March 2020

1 reference

Changing human behavior to prevent disease: the importance of targeting automatic processes.

31 March 2020

1 reference

Cancer treatment and survivorship statistics, 2012

31 March 2020

1 reference

The role of physical activity in breast cancer etiology.

31 March 2020

1 reference

Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review

31 March 2020

1 reference

The convergent development of molecular-targeted drugs for cancer treatment and prevention

31 March 2020

1 reference

31 March 2020

1 reference

Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward

31 March 2020

1 reference

Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

31 March 2020

1 reference

Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis

31 March 2020

1 reference

Long-term metformin use is associated with decreased risk of breast cancer.

31 March 2020

1 reference

Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents

31 March 2020

1 reference

Breast cancer prevention trials: large and small trials

31 March 2020

1 reference

Overview of the main outcomes in breast-cancer prevention trials

31 March 2020

1 reference

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

31 March 2020

1 reference

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer

31 March 2020

1 reference

Aromatase inhibitors for breast cancer prevention

31 March 2020

1 reference

Exemestane for breast-cancer prevention in postmenopausal women.

31 March 2020

1 reference

Exemestane for breast cancer prevention: a critical shift?

31 March 2020

1 reference

A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer

31 March 2020

1 reference

A randomized trial of aspirin to prevent colorectal adenomas

31 March 2020

1 reference

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

31 March 2020

1 reference

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials

31 March 2020

1 reference

Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials

31 March 2020

1 reference

Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials.

31 March 2020

1 reference

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

31 March 2020

1 reference

Celecoxib for the prevention of colorectal adenomatous polyps

31 March 2020

1 reference

Celecoxib for the prevention of sporadic colorectal adenomas

31 March 2020

1 reference

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

31 March 2020

1 reference

Rofecoxib and Cardiovascular Adverse Events in Adjuvant Treatment of Colorectal Cancer

31 March 2020

1 reference

Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk

31 March 2020

1 reference

Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial

31 March 2020

1 reference

The influence of finasteride on the development of prostate cancer

31 March 2020

1 reference

Effect of dutasteride on the risk of prostate cancer

31 March 2020

1 reference

The prevention of prostate cancer--the dilemma continues

31 March 2020

1 reference

Chemoprevention of Prostate Cancer

31 March 2020

1 reference

Finasteride metabolism and pharmacogenetics: new approaches to personalized prevention of prostate cancer.

31 March 2020

1 reference

Physical activity, television viewing and body mass index: a cross-sectional analysis from childhood to adulthood in the 1958 British cohort

31 March 2020

1 reference

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

31 March 2020

1 reference

Prevalence of tamoxifen use for breast cancer chemoprevention among U.S. women.

31 March 2020

1 reference

Tamoxifen infrequently used by women at risk for breast cancer

31 March 2020

1 reference

Vaccines to prevent infections by oncoviruses

31 March 2020

1 reference

Human papillomavirus infection and the primary and secondary prevention of cervical cancer.

31 March 2020

1 reference

Focus on research: weighing the benefits and costs of HPV vaccination of young men

31 March 2020

1 reference

Prevalence of oral HPV infection in the United States, 2009-2010.

31 March 2020

1 reference

Targeted human papillomavirus vaccination of men who have sex with men in the USA: a cost-effectiveness modelling analysis

31 March 2020

1 reference

Human papillomavirus immunogen that provides protective tumor immunity and induces tumor regression

31 March 2020

1 reference

Prevalence of HPV infection among females in the United States

31 March 2020

1 reference

Vaccine prevention of cancer: can endogenous antigens be targeted?

31 March 2020

1 reference

Use of tumour-responsive T cells as cancer treatment

31 March 2020

1 reference

Vaccine against MUC1 antigen expressed in inflammatory bowel disease and cancer lessens colonic inflammation and prevents progression to colitis-associated colon cancer

31 March 2020

1 reference

Pilot study of vaccination with recombinant CEA-MUC-1-TRICOM poxviral-based vaccines in patients with metastatic carcinoma

31 March 2020

1 reference

The diversity of T-cell co-stimulation in the induction of antitumor immunity

31 March 2020

1 reference

Treatment of vulvar intraepithelial neoplasia with topical imiquimod

31 March 2020

1 reference

Immunomodulation by imiquimod in patients with high-risk primary melanoma

31 March 2020

1 reference

Inhibition and promotion of tumor growth with adeno-associated virus carcinoembryonic antigen vaccine and Toll-like receptor agonists

31 March 2020

1 reference

Toll-like receptor 4 mediates induction of the Bcl10-NFkappaB-interleukin-8 inflammatory pathway by carrageenan in human intestinal epithelial cells

31 March 2020

1 reference

Suppression of allergic reaction by lambda-carrageenan: toll-like receptor 4/MyD88-dependent and -independent modulation of immunity

31 March 2020

1 reference

Carrageenan is a potent inhibitor of papillomavirus infection

31 March 2020

1 reference

A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the International Bladder Cancer Group

31 March 2020

1 reference

Long-term follow-up of T1 high-grade bladder cancer after intravesical bacille Calmette-Guérin treatment

31 March 2020

1 reference

Markers predicting response to bacillus Calmette-Guérin immunotherapy in high-risk bladder cancer patients: a systematic review

31 March 2020

1 reference

Tumor Immunotherapy Directed at PD-1

31 March 2020

1 reference

Biomarkers for early detection and as surrogate endpoints in cancer prevention trials: issues and opportunities

31 March 2020

1 reference

Mammographic density and breast cancer risk: current understanding and future prospects

31 March 2020

1 reference

Molecular markers for early detection

31 March 2020

1 reference

Prognostic and predictive markers in stage II colon cancer: is there a role for gene expression profiling?

31 March 2020

1 reference

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

31 March 2020

1 reference

Lasofoxifene in postmenopausal women with osteoporosis

31 March 2020

1 reference

Breast cancer incidence in the randomized PEARL trial of lasofoxifene in postmenopausal osteoporotic women.

31 March 2020

1 reference

Arzoxifene for prevention of fractures and invasive breast cancer in postmenopausal women

31 March 2020

1 reference

IBIS II: a breast cancer prevention trial in postmenopausal women using the aromatase inhibitor anastrozole

31 March 2020

1 reference

Tamoxifen-Induced Reduction in Mammographic Density and Breast Cancer Risk Reduction: A Nested Case-Control Study

31 March 2020

1 reference

Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer

31 March 2020

1 reference

Effect of raloxifene on mammographic density and breast magnetic resonance imaging in premenopausal women at increased risk for breast cancer

31 March 2020

1 reference

31 March 2020

Overdiagnosis in cancer

1 reference

Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis

31 March 2020

1 reference

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study

31 March 2020

1 reference

Design of the Women’s Health Initiative Clinical Trial and Observational Study

31 March 2020

1 reference

The use of animal models for cancer chemoprevention drug development

31 March 2020

1 reference

American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction

31 March 2020

1 reference

The lack, need, and opportunities for decision-making and informational tools to educate primary-care physicians and women about breast cancer chemoprevention

31 March 2020

1 reference

Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis

31 March 2020

1 reference

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement

31 March 2020

1 reference

Public health. Brawling over mammography

31 March 2020

1 reference

Reduced lung-cancer mortality with low-dose computed tomographic screening

31 March 2020

1 reference

Colorectal cancer: chemopreventive role of curcumin and resveratrol

31 March 2020

1 reference

Coordinate linkage of HIV evolution reveals regions of immunological vulnerability

31 March 2020

1 reference

Preliminary study of two antiviral agents for hepatitis C genotype 1.

31 March 2020

1 reference

Hepatitis C virus prevention, care, and treatment: from policy to practice

31 March 2020

1 reference

Development of a DNA vaccine targeting Merkel cell polyomavirus

31 March 2020

1 reference

HER-2/neu as a target for cancer vaccines

31 March 2020

1 reference

Comparison of different HER2/neu vaccines in adjuvant breast cancer trials: implications for dosing of peptide vaccines.

31 March 2020

1 reference

Insulin-like growth factor-binding protein-2 is a target for the immunomodulation of breast cancer

31 March 2020

1 reference

NY-ESO-1: review of an immunogenic tumor antigen

31 March 2020

1 reference

AFP-specific immunotherapy impairs growth of autochthonous hepatocellular carcinoma in mice

31 March 2020

1 reference

Prevention of colitis-associated colon cancer using a vaccine to target abnormal expression of the MUC1 tumor antigen

31 March 2020

1 reference

MAGE-A antigens as targets in tumour therapy

31 March 2020

1 reference

Immunization with mutant p53- and K-ras-derived peptides in cancer patients: immune response and clinical outcome

31 March 2020

1 reference

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

31 March 2020

1 reference

A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes

31 March 2020

1 reference

A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma

31 March 2020

1 reference

A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma.

31 March 2020

1 reference

Systematic review: comparative effectiveness of medications to reduce risk for primary breast cancer

31 March 2020

1 reference

12 December 2020

Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group

1 reference

12 December 2020

Selenium and Vitamin E Cancer Prevention Trial: a nutrient approach to prostate cancer prevention

1 reference

12 December 2020

Recognition of BCR-ABL positive leukemic blasts by human CD4+ T cells elicited by primary in vitro immunization with a BCR-ABL breakpoint peptide

1 reference

12 December 2020

Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement

1 reference

12 December 2020

Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement

1 reference

12 December 2020

Field effect in cancer-an update

1 reference

12 December 2020

Food, nutrition, and the prevention of cancer: a global perspective. American Institute for Cancer Research/World Cancer Research Fund, American Institute for Cancer Research, 1997.

1 reference

12 December 2020

A dose-finding study of aspirin for chemoprevention utilizing rectal mucosal prostaglandin E(2) levels as a biomarker

1 reference

12 December 2020

Diet and cancer: one view at the start of the millennium.

1 reference

12 December 2020

Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids)

1 reference

12 December 2020

Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial

1 reference

12 December 2020

Physical activity and cancer: an introduction.

1 reference

12 December 2020

Use of two predictive algorithms of the world wide web for the identification of tumor-reactive T-cell epitopes.

1 reference

12 December 2020

Recombinant cancer vaccines based on viral vectors.

1 reference

12 December 2020

Anti-idiotypic single chain mimicking CA125 linked with tuftsin provides protective immunity against ovarian cancer in mice

1 reference

12 December 2020

Global estimates of cancer prevalence for 27 sites in the adult population in 2008.

1 reference

12 December 2020

The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRC3397

1 reference

Dimensions Publication ID

28 August 2017

0 references

1 reference